Photo from Paolo Tarantino/Twitter
Jun 14, 2023, 18:35
Can we improve the delivery of eribulin by linking it to a HER2 mAb?
In a post by Paolo Tarantino on Twitter, it says, “Can we improve the delivery of eribulin by linking it to a HER2 mAb? In a cohort of 29 patients with HER2-expressing tumors (65% breast), BB-1701 achieved an ORR of 50% (70% for breast), with durable responses. High rates of peripheral neuropathy (69%).”
Source: Paolo Tarantino/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 14:35
Dec 22, 2024, 14:32
Dec 22, 2024, 14:19
Dec 22, 2024, 13:56
Dec 22, 2024, 13:45